Lynn Ong is Head of Communications, Asia Pacific for the Crop Science Division of Bayer AG, one of the world’s leading innovative crop science companies in the areas of seeds & traits, crop protection and digital farming solutions.

In her role, she is responsible for providing leadership and strategic direction for the organization’s internal and external communications activities in the region, to shape public perception and position Bayer as a market leader in agriculture. Prior to joining Bayer in 2012, Lynn was Head of Communications for IHS in Asia Pacific (now known as IHS Markit), and before this, Head of Media Relations for Asia Pacific and Japan with SAP.

Lynn is a communications professional with over 20 years’ experience with major MNCs and well-known brand name companies, including Bayer, IHS, SAP, NCS – a subsidiary of the SingTel Group, as well as the Singapore Land Transport Authority. With a wealth of experience in employee communications, media relations, crisis management, public affairs and change management, Lynn was also the corporate media spokesperson for the companies in her previous roles.

Based in Singapore, Lynn has undertaken regional communications roles in the span of her career, covering key markets in the Asia Pacific region including Australia, China, India, Japan, South Korea and Southeast Asia. She is fluent in both English and Chinese.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 5.3 billion euros. For more information, go to www.bayer.com.